You have 9 free searches left this month | for more free features.

Beijing (1)

Melanoma (1)

Not yet recruiting (1)

phase 3 (1)

Shanghai Kechow Pharma, Inc. (1)

paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin (1)

tunlametinib (1)

drug (1)

Industry (1)

Interventional (1)

tunlametinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Aug 15, 2023